MiRXES

Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx - THE EDGE SINGAPORE

IPO

Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx

The funding came from new and existing investors including EDB Investments Pte Ltd.
Mirxes denies Bloomberg article on IPO plans, says source was "not from the company"   - THE EDGE SINGAPORE

IPO

Mirxes denies Bloomberg article on IPO plans, says source was 'not from the company'

The company also has denied any formal plans to go public via a de-SPAC in the US.

IPO

Biotech startup Mirxes weighs US$300 mil Singapore IPO

Any listing would help to further stimulate the IPO market in Singapore.

Special Event

Nominations open for this year's EY Entrepreneur Of The Year

The Edge Singapore is again one of the media partners of this awards

EY Entrepreneur Of The Year 2021 Awards Singapore

A desire to improve and save lives through preventive healthcare

Founders of biotech company MiRXES were working on the PCR technology well before Covid-19 struck

EY Entrepreneur Of The Year 2021 Awards Singapore

A very promising cohort

The environment is tough but Loh is also cheered by the success of entrepreneurs here

EY Entrepreneur Of The Year 2021 Awards Singapore

Founders of biotech firm MiRXES win top honours at 20th EY Entrepreneur Of The Year

MiRXES tells a powerful story of how the combination of science and entrepreneurship can significantly impact human lives
Founders o Covid-19 testing kit maker MiRXES named EY Entrepreneur Of The Year   - THE EDGE SINGAPORE

EY Entrepreneur Of The Year 2021 Awards Singapore

Founders of Covid-19 testing kit maker MiRXES named EY Entrepreneur Of The Year

MiRXES's ability to mass-produce Covid-19 test kits were instrumental to Singapore's fight against the pandemic
MiRXES appoints David Capes as new global head of innovation - THE EDGE SINGAPORE

New appointments

MiRXES appoints David Capes as new global head of innovation

Capes is based in Singapore and will report to MiRXES’ co-founder and CEO, Dr Zhou Lihan.
×